Literature DB >> 4952936

Human plasma kallikrein, its activation and pathological role.

M E Webster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4952936

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  12 in total

1.  Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.

Authors:  A S Weiss; J I Gallin; A P Kaplan
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

Authors:  S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

3.  On the endogenous mechanism of kinin release. I. Attempts at discriminating kallikreins.

Authors:  R Jahrreiss; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  The profile of vascular permeability factors in dilute guinea-pig plasma.

Authors:  B Mason
Journal:  Br J Exp Pathol       Date:  1972-12

5.  Studies on the prekallikrein-bradykininogen system in liver disease.

Authors:  D Stewart; L M Blendis; R Williams
Journal:  J Clin Pathol       Date:  1972-05       Impact factor: 3.411

6.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

7.  Human plasma kallikrein. A rapid purification method with high yield.

Authors:  H Nagase; A J Barrett
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

8.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

9.  Anaphylactic release of a prekallikrein activator from human lung in vitro.

Authors:  H L Meier; A P Kaplan; L M Lichtenstein; S Revak; C G Cochrane; H H Newball
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.